Log in
Enquire now
‌

US Patent 8728794 Strain conferring anti-disease properties to host and bacterial cell composition

Patent 8728794 was granted and assigned to Meiji Seika Pharma on May, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

The present invention provides a novel bacterial cell composition which comprises cells of Butyrivibrio fibrisolvens having the ability to produce butyric acid, a cultured material thereof or an extract thereof, and a method for inhibiting carcinogenesis, a method for immunostimulating, a method for preventing or treating a pathogen, a method for preventing or treating an inflammatory bowel disease and a method for preventing or treating an allergic disease, which use the same.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8728794 Strain conferring anti-disease properties to host and bacterial cell composition

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.